Pfizer To Benefit From Early FDA Approval For Breast Cancer Drug
February 04, 2015 at 20:49 PM EST
Although approval of palbociclib was expected, the early nod is a surprise.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.